Sagility Acquires U.S. Healthcare Analytics Firm CareSeed to Boost AI-Led Quality Operations

$SAGILITY has announced the 100% acquisition of CareSeed, a U.S.-based healthcare analytics company, with the transaction expected to close on June 11, 2026. The deal is expected to be EPS accretive and marks a significant step in Sagility’s evolution into a tech and AI-driven quality operations partner. Target Profile (CareSeed): Background: Founded in 2012 and headquartered in Kansas City, MO; serves 30 small and mid-sized U.S. health payers. Core Offerings: NCQA-certified HEDIS quality reporting, medical record review, and regulatory analytics via its cloud-native Forecast and Harvest platforms. Financial Snapshot (CY25): Revenue of $5.1 million and EBITDA of $1.6 million (31.4% margin). Strategic Rationale: AI & Tech Integration: Integrates CareSeed’s platforms to transition health plans from retrospective HEDIS reporting to proactive, AI-led quality operations, care gap orchestration, and continuous performance monitoring. Medicare Advantage Expansion: Deepens Sagility’s footprint in the Medicare Advantage and Quality Services market, enhancing capabilities in CMS Stars and quality measurement to help payers optimize Medical Loss Ratio (MLR) and value-based reimbursements. New Client Acquisition & Cross-Selling: Brings in 28 new small and mid-sized health plan relationships, creating immediate cross-sell opportunities for Sagility’s broader Business Process as a Service (BPaaS) model. Talent Infusion: Adds specialized expertise in healthcare quality technology, sales, and client management to Sagility’s existing workforce. Outlook: This acquisition accelerates Sagility’s shift toward a high-margin, technology-led operating model. By combining CareSeed's specialized analytics with Sagility's operational scale, the deal is poised to drive recurring revenue, deepen client stickiness, and deliver long-term shareholder value in the lucrative U.S. healthcare quality market.